Q-linea as an investment
Welcome to the Investor Relations section. Here we have gathered important information about Q-linea for existing investors and others who are interested in our business.
NASDAQ Stockholm(QLINEA): Quotes are delayed 15 minutes
24.94
SEK0.79
percentQ-linea as an investment
Welcome to the Investor Relations section. Here we have gathered important information about Q-linea for existing investors and others who are interested in our business.
NASDAQ Stockholm(QLINEA): Quotes are delayed 15 minutes
24.94
SEK0.79
percentFuture-proof Healthcare
CEO Jonas Jarvius explains how Q-linea is intimately tied to his experiences of healthcare inequity, and how Q-linea is working to ensure we have sustainable and equitable healthcare, now and in the future.
Press releases
Q-linea signs first distribution agreement in South Asia
Q-linea AB (publ) (OMX: QLINEA) today announces it will provide ASTar® to Italian users of the Accelerate Pheno rapid AST system
Q-linea announces first two US hospital systems’ clinical implementation of ASTar®
Q-linea AB (Publ) (OMX: QLINEA) announces the clinical implementation of the first US ASTar instruments at UI (University of…
Read more >
Keep up to date – subscribe
Christer Samuelsson
Investor Relations
Phone: +46 18 444 36 10
Mobile: +46 70 600 15 20
.
.
.